Healthcare Businesses for Sale and Investment Opportunities

- The company is a bio-medical startup based in Mumbai with a current manufacturing capacity of 20,000 units and is seeking investment to scale marketing, distribution, and assembly. - The heart rate monitor is the top-selling product, with an average of 200 units sold per month through online channels such as the company's website and Amazon. Revenue sources are diversified, with 40% of sales revenue coming from Amazon and 60% from the company's website. The company utilizes Ship Rocket and Amazon for logistics. - The company's current sales are entirely business-to-consumer (B2C) - The company has garnered interest from Bridge Health and Fitterfly for the use of its product in BP reduction programs, showcasing the potential for further B2B partnerships. - The heart rate monitor is currently sold at an introductory price of INR 1,999 for the first 1,000 devices, with the regular price set at INR 3,499. The company aims to sell approximately 1 lakh units by the end of the year. - The product current has a +/- 2 points tolerance, which shows they are 98% accurate. - Collaborating with telemedicine doctors. - The company has currently outsourced manufacturing with a manufacturing capacity of approximately 20,000 units manufactured a month and we have our own testing and assembly rigs to avoid any leaking of design and work. - The business already has a ready stock of more than 10,000 units in inventory and is sending them for testing to its partners. - The business holds the necessary GST certificate & an ISO 13485 certificate.

- A biotech firm based in Milan, focusing on cancer immuno personalized therapy. - Has a portfolio of R&D projects and two Finished Dosage Forms (FDF) in the Italian market, including Aripiprazole and Emtricitabine + Tenofovir. - The company specializes in the development of microfluidic technology for the production and purification of Exosomes, with applications in anti-inflammatory, skin regenerative, anti-acne and atopic dermatitis, scalp rejuvenation, and hair growth treatments. - Exosomes, a key product of the company, are body-identical ingredients known for their high stability and low likelihood of causing adverse reactions. Their cell-penetrating mechanism enables them to deliver regeneration signals, making them suitable for diverse medical and cosmetic applications. - Has 3 major clients and supplied on a quarterly basis to pharmaceutical companies in Italy, Poland, and Brazil. - Operates with a network of 12 agents in addition to its 3 permanent employees. - Collaborates with Contract Manufacturing Organizations (CMOs) for the production of its pharmaceutical products. The company holds essential regulatory licenses from GMP, FDA, and the Ministry of Health, ensuring compliance with international quality and safety standards.

- Located in Singapore, our spin studio offers both spin classes and corporate events tailored for team building. - We provide membership and package options to cater to diverse customer needs. - Currently, we serve over 500 riders through our platform and partner bookings, with substantial room for expansion. - Our studio boasts a loyal and committed rider base, contributing to our sustained success. - With a well-established and reputable brand, we have the potential to replicate our business model locally and internationally. - Positioned strategically, we face minimal direct competition in our area. - Licensed and incorporated, we operate with compliance and professionalism. - Our team consists of 11 experienced and dedicated coaches, ensuring quality instruction and customer satisfaction.

- Business is revolutionizing the management of chronic and neuropathic pain in India with a focus on safety and efficacy. - Our licensed healthcare company is pioneering the country's first range of GMP-compliant, lab-certified, ayurvedic cannabinoid formulations designed to provide patients with a natural alternative to traditional pain medications. - First mover advantage: First to bring cannabinoid based pain management solutions into mainstream healthcare and retail in India. - Onco Range: Launched India's first and only Onco-focused range of CBD formulations addressing big problem areas in cancer care. - Endorsement from the medical community: Extensive inroads into the medical community with KOL's prescribing and endorsing our medications. - Backed by clinical trials: 1st Indian company to conduct clinical trials and bring CBD-based pain management products into mainstream healthcare and retail. - Extensive distribution: Access to extensive distribution through partnerships with the largest healthcare and big box companies such as Apollo, Guardian, Genisan Healthcare, Max Group, Spencer’s Retail, and Nature Basket. - Traction: Since last year, 9X growth in Offline sales and 3X growth in sales. - Marquee investors onboarded from Apollo Hospital, Panthera Peak Ventures, IIFL Finance,  Mahindra First. - The business has all the required licenses and certifications.

- Drug reformulation pharmaceutical company based in Los Angeles. - Focused on developing drugs through Phase I to IV to achieve FDA approval. - Primarily directed towards improving health outcomes in the neurosciences and beyond. - Dedicated to finding innovative and effective treatment solutions to the most challenging ailments related to the Central Nervous System. - This is done by transforming positive clinical results from decades of hands-on patient care experience into rigorous scientific research. - The company has 10 patented products in its portfolio, some of which have the potential to generate annual revenues ranging from $200 million to $1 billion per product. - 4 of these products need to be moved to Phase IIb. - The products cater to critical healthcare needs in America and are planned to be established through publication on popular channels to showcase the efficacy. - Also has a network of 70,000 pharmacies, providing a robust distribution platform for its products. - While the company owns the formulation of its products, the production is outsourced through external laboratories. - Led by 8 partners with over 100 years of combined professional experience in patient care, clinical research, and entrepreneurship. They bring vast experience in CNS-related drug development, ensuring a strong foundation for the company's operations.

- We are a cardiac centre located in a 30-year-old hospital. - The cardiac centre is not owned by the hospital but is a separate entity and we use the hospital's premises and work on a profit-sharing model. - The business has been operational for 6 months. - Receive 50 patients on a daily basis. - Revenue is generated from providing medical services. - We have a high number of employees to keep up with the patients that we cater to. - Promoters have more than 18 years of experience and are well-established. - The business only has a registration certificate and is not NABH-accredited.